secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0000313143-22-000059
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics files 8-K for Q2 FY2023 results; filing lacks specific financial figures
--------------------------------------------------------------------------------

- Company issued press release for Q2 ended October 1, 2022 and first half FY2023 results.
- Filing only references Exhibit 99.1; actual financial data not included in provided text.
- Confidence in event detail is low due to absence of numbers in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000059/0000313143-22-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000059/hae-20221107.htm
  HTML page:      https://secwatch.observer/filing/0000313143-22-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer